LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Jury Punishes Wright Medical With $11 Million Verdict Over Conserv Hip
Legal & Regulatory and Reimbursement

Jury Punishes Wright Medical With $11 Million Verdict Over Conserv Hip

December 3, 2015 2 min read Premium comments

Advertisement

Jury Punishes Wright Medical With $11 Million Verdict Over Conserv Hip
Photo creation by RRY Publications, LLC
Secondary

Another metal-on-metal hip maker has lost a bellwether trial in a federal court.

After a two week trial, a federal jury in Atlanta awarded $11 million to Robyn Christiansen, a retired ski instructor implanted with an allegedly defective metal-on-metal hip implant made by Wright Medical Technology, Inc.

The jury, according to the Atlanta Journal-Constitution, deliberated for three days and reached the verdict on November 25, 2015. The jury awarded Christiansen $1 million in compensatory damages and a whopping $10 million in punitive damages. Wright Medical’s senior vice president and chief communication officer, Julie Tracy, said the company disagrees with the verdict, and “are considering all of our post-trial options and expect that we will appeal the decision if it is permitted to stand.”

The metal-on-metal hip implant, the Conserv Plus, was found to be defective and the company was held liable for negligent misrepresentation about the device.

This was the first of more than 300 cases that are part of a multi-district litigation case before U.S. District Judge Bill Duffey in Atlanta. There are also hundreds of other cases against the company in a state court in Los Angeles.

Christiansen’s was implanted with the hip device in April 2006, but the device failed after six years. She was then forced to have the implant removed. During that procedure, her surgeon found fluid buildup, tissue necrosis and metallosis, requiring the removal of soft tissue damaged by metal debris, according to a statement from her legal team.

Christiansen’s case was one of ten selected to go through a mediation and trial program. When mediation failed, her case was picked to be the first one to go to trial.

Wright Medical sold its hip and knee implant business to China-based MicroPort Medical in 2013 for $290 million.

Advertisement

Metal-on-metal hips have been very controversial after foreign registries showed higher than normal failure rates. On May 6, 2011, the FDA ordered manufacturers of metal-on-metal hip devices to conduct postmarket surveillance.

Thousands of lawsuits have been filed around the country by patients who have alleged injury from their metal-on-metal hip implants made by various manufacturers. The multi-district cases, in addition to Wright Medical’s, include:

  • Zimmer Holding’s Durom Hip Cup (290 filed cases)
  • DePuy Orthopaedics, Inc.’s ASR Hip Implant (8, 858 filed cases)
  • DePuy Orthopaedics, Inc.’s Pinnacle Hip Implant (5, 153 filed cases)
  • Biomet, Inc.’s M2a Magnum Hip Implant (978 filed cases)

DePuy has reached a multi-billion dollar settlement with patients implanted with the ASR implant.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy